| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/09/2008 | US7422743 Using DCRS5 (SEQ ID NOs: 1 or 2) or p19 (SEQ ID NOs: 5 or 6) cytokine receptors agonist or antagonist to treat rheumatoid arthritis, asthma, allergies, chronic obstructive pulmonary disorder, interstitial lung disorder, inflammatory bowel disorder, inflammatory skin disorder |
| 09/09/2008 | US7422741 VEGFR-3 fusion proteins |
| 09/09/2008 | US7422740 Capable of inhibiting the cell division cycle in a target cell; for therapy of proliferative cell disorders and intracellular pathogens |
| 09/09/2008 | CA2622649A1 Primer, primer set, and nucleic acid amplification method and mutation detection method using the same |
| 09/09/2008 | CA2449254C Alteration of oil traits in plants |
| 09/09/2008 | CA2419696C Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes |
| 09/09/2008 | CA2347160C Method of separating hemoglobin a2 |
| 09/09/2008 | CA2323086C Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/09/2008 | CA2306820C Improved methods for producing factor viii proteins |
| 09/09/2008 | CA2251842C Small molecule mimetics of erythropoietin |
| 09/09/2008 | CA2173999C An aglucone isoflavone enriched vegetable protein whey, whey protein, and process for producing |
| 09/09/2008 | CA2144855C Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 09/09/2008 | CA2135833C Antigen carbohydrate compounds and their use in immunotherapy |
| 09/04/2008 | WO2008106660A2 Isolated phospholipid-protein particles |
| 09/04/2008 | WO2008106551A2 Brachyury polypeptides and methods for use |
| 09/04/2008 | WO2008106429A2 Methods and compositions for the treatment of heart failure and other disorders |
| 09/04/2008 | WO2008105901A2 Modified clostridial toxins with enhanced translocation capability and enhanced targeting activity |
| 09/04/2008 | WO2008105890A2 Chloroplast transit peptides for efficient targeting of dmo and uses thereof |
| 09/04/2008 | WO2008105797A2 Polynucleotides encoding novel pcsk9 variants |
| 09/04/2008 | WO2008105630A1 Combined use of cell permeable nanog and oct4 for increasing self-renewal and suppressing differentiation of stem cells |
| 09/04/2008 | WO2008105462A1 Method for activation of helper t cell and composition for use in the method |
| 09/04/2008 | WO2008105215A1 Marker peptide for diagnosis of alcoholic liver disease, and method for diagnosis of alcoholic liver disease using the same |
| 09/04/2008 | WO2008105178A1 Agent for enhancing the resistance of liposome against biological component, and liposome modified with the agent |
| 09/04/2008 | WO2008104890A2 Compositions and methods for producing apolipoprotein |
| 09/04/2008 | WO2008104808A2 Compounds and methods for the modulation of beta-1 integrin function to mediate tissue repair |
| 09/04/2008 | WO2008104805A2 Proteins |
| 09/04/2008 | WO2008104804A2 Proteins |
| 09/04/2008 | WO2008104803A2 Proteins |
| 09/04/2008 | WO2008104777A2 Peptide |
| 09/04/2008 | WO2008104575A2 Immune system mediator |
| 09/04/2008 | WO2008104372A1 Method for the purification of recombinant blood coagulation factor ix enriched in sulfated and/or phosphorylated molecules |
| 09/04/2008 | WO2008104321A1 Method for the selective determination of procalcitonin 1-116 for diagnostic purposes and antibodies and kits for carrying out such a method |
| 09/04/2008 | WO2008104183A2 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 09/04/2008 | WO2008104062A2 Selective release of pro-apoptotic bcl-2 family members and their contribution to the bystander effect |
| 09/04/2008 | WO2008087189A3 Peptides for use in the treatment of obesity |
| 09/04/2008 | WO2008087188A3 Peptides for use in the treatment of obesity |
| 09/04/2008 | WO2008086634A3 Chimeric umami taste receptor, nucleic acid encoding it and use thereof |
| 09/04/2008 | WO2008086524A3 Alpha-1-antitrypsin variants and uses thereof |
| 09/04/2008 | WO2008048670A3 Compositions and methods for modulating tlr14 activity |
| 09/04/2008 | WO2007095469A8 Identification and use of target genes for control of plant parasitic nematodes |
| 09/04/2008 | WO2007082379A8 Method to identify cd40-sensitive cells using gene expression |
| 09/04/2008 | WO2007044396A3 Fibronectin polypeptides and methods of use |
| 09/04/2008 | WO2006047535A3 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 09/04/2008 | WO2005025489A3 Therapeutic use of g53135-05(fgf-20) in radiation protection |
| 09/04/2008 | WO1997013786A9 Streptoccal inhibitor of complement-mediated lysis, protein sic |
| 09/04/2008 | US20080216200 Alternative splicing factors polynucleotides, polypeptides and uses thereof |
| 09/04/2008 | US20080216199 removing molybdenum from a molybdenum-containing soil environment by growing a transgenic plant having a molybdenum transporter activity |
| 09/04/2008 | US20080216196 Environmental stress-responsive promoter and a gene encoding environmental stress-responsive transcriptional factor |
| 09/04/2008 | US20080216193 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 09/04/2008 | US20080216184 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms |
| 09/04/2008 | US20080214811 Xanthene dyes |
| 09/04/2008 | US20080214794 Method and device for extracting an analyte |
| 09/04/2008 | US20080214792 Isolating muscle protein from connective tissue via slurries, ultrasonic agitation and reservoir separation |
| 09/04/2008 | US20080214790 Leafthopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 09/04/2008 | US20080214788 Interferon-like protein zcyto21 |
| 09/04/2008 | US20080214785 Heterodimeric receptor complex which antagonizes IL-10-related T cell-derived inducible factor for use in diagnosis, treatment and prevention of spleen associated cell proliferative disorders |
| 09/04/2008 | US20080214784 Human t1r2 taste receptor polypeptides |
| 09/04/2008 | US20080214781 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 09/04/2008 | US20080214695 Biocompatible crosslinked polymers with visualization agents |
| 09/04/2008 | US20080214517 Modulation of the Expression of Estrogen Receptors for the Prevention or Treatment of Heart Disease |
| 09/04/2008 | US20080214487 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 09/04/2008 | US20080214471 Method for inhibition of viral infection |
| 09/04/2008 | US20080214467 Exendins and Exendin Agonists Modified with Albumin |
| 09/04/2008 | US20080214466 Daily intravenous administration of VEGFR1R2-Fc Delta C1 or coadministration with a cytotoxic, chemotherapeutic or antigrowth agent, while gradually decreasing dosage of the antagonist; pancreatic cancer |
| 09/04/2008 | US20080214465 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 09/04/2008 | US20080214464 Method for the Production of Biologically Active Rhngf |
| 09/04/2008 | US20080214463 Method for cell adhesion and wound healing |
| 09/04/2008 | US20080214462 FIX-Mutant Proteins for Hemophilia B Treatment |
| 09/04/2008 | US20080214461 FVIII-Independent FIX-Mutant Proteins for Hemophilia A Treatment |
| 09/04/2008 | US20080214457 Isolated peptide, polynucleotide that encodes a peptide that is from 10 to 100 amino acids in length |
| 09/04/2008 | US20080214454 Use of HMGB fragments as anti-inflammatory agents |
| 09/04/2008 | US20080214451 Chimeric polypeptide; a first domain, a first intracellular loop (i1 loop) or a fragment of a G protein coupled receptor, and a second domain, attached to the first domain, a naturally or non-naturally occurring cell-penetrating, membrane-tethering hydrophobic group |
| 09/04/2008 | US20080214450 Nucleic acid constructs, recombinant expression vectors, and recombinant host cells comprising the polynucleotides |
| 09/04/2008 | US20080214442 Fucose-containing glycoprotein; kits |
| 09/04/2008 | US20080214440 Pituitary adenylate cyclase activating peptide; solid phase synthesis; diabetes, insulin resistance, metabolic acidosis and obesity |
| 09/04/2008 | US20080213918 Polynucleotides encoding two novel human G-protein coupled receptors, HGPRBMY28 and HGPRBMY29, and splice variants thereof |
| 09/04/2008 | US20080213917 Hydroxy-isophthalamide moieties; antibodies; high stability, luminescence; kits |
| 09/04/2008 | US20080213907 Protein markers for the diagnosis and prognosis of ovarian and breast cancer |
| 09/04/2008 | US20080213898 Compositions and methods for nucleic acid delivery |
| 09/04/2008 | US20080213886 Albumin fusion proteins |
| 09/04/2008 | US20080213881 Expression vector coding nucleotide sequences comprising novel cytokine upregulated by interleukin-9 for use in treatment and prevention of cell hodgkin's disease |
| 09/04/2008 | US20080213880 Chimeric t1r1 taste receptor encoding nucleic acid sequences and vectors |
| 09/04/2008 | US20080213879 Chimeric GFP-aequorin as bioluminescent Ca++ reporters at the single cell level |
| 09/04/2008 | US20080213878 Novel human membrane proteins and polynucleotides encoding the same |
| 09/04/2008 | US20080213839 Nucleotide sequences coding stem cell factors for use as therapeutic tools in treating learning and memory disorders |
| 09/04/2008 | US20080213837 Apo-3 ligand polypeptide |
| 09/04/2008 | US20080213836 Modified enteropeptidase protein |
| 09/04/2008 | US20080213833 Methods for Obtaining Optically Active Glycidyl Ethers and Optically Active Vicinal Diols from Racemic Substrates |
| 09/04/2008 | US20080213832 Sesquiterpene synthases and methods of use |
| 09/04/2008 | US20080213831 Human cytokine receptor |
| 09/04/2008 | US20080213828 Glycoprotein synthesis |
| 09/04/2008 | US20080213822 Methods for diagnosing celiac sprue and reagents useful therein |
| 09/04/2008 | US20080213803 Using proopiomelanocortin neuronal regulatory sequences to identify agents that affects caloric intake, energy expenditure, appetite or food intake; treating eating disorders and/or cachexia |
| 09/04/2008 | US20080213798 Novel c. elegans p21-activated kinase (pak) gene and associated loss-of-function phenotypes that facilitate screening for small molecule modulators of pak activity in the nematode, caenorhabditis elegans |
| 09/04/2008 | US20080213796 GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity |
| 09/04/2008 | US20080213795 Plasmodium epitope polypeptide for use in treatment and prevention malarial infection |
| 09/04/2008 | US20080213793 Antibodies that bind receptor protein designated 2f1 |
| 09/04/2008 | US20080213779 Using variation in NLR family, pyrin domain containing 7 (NALP7) gene as evaluative tool in diagnosis/prognosis of gestation disorders |
| 09/04/2008 | US20080213778 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 09/04/2008 | US20080213777 Using malignant brain tumor (MBT) repeat protein (LIN-61) as tool in identifying modulators for prevention and treatment of cell proliferative disorders |